Department of Medicine. The Harm Reduction Debate Current context of the debate - Snus enthusiasts vs. pessimists Switching from cigarettes to snus alone.

Slides:



Advertisements
Similar presentations
NATIONAL TOBACCO CONTROL 1. PREVENT TOBACCO USE AMONG YOUTH 2. REDUCE NUMBERS OF SMOKERS REDUCE TOBACCO CONSUMPTION 3. LIMIT ENVIRONMENTAL TOBACCO SMOKE.
Advertisements

 2007 Johns Hopkins Bloomberg School of Public Health Section B Non-Combusting Products and Oral Products.
New Tobacco Products: Harm Reduction or Harm Induction? Herbert H. Severson Senior Research Scientist Oregon Research Institute Eugene, Oregon.
Results Introduction Tobacco use is the leading preventable cause of death in Wisconsin and the United States. Given the risk of smoking initiation during.
Reducing the toll of smoking-related disease and death: The case for tobacco harm reduction The rationale for establishing low-toxicity smokeless nicotine.
UNIVERSITY OF MARYLAND SCHOOL OF LAW The Basis of a Comprehensive Regulatory Policy for Reduced Harm Tobacco Products David Sweanor, Adjunct Professor.
Taxing New Tobacco Products: Strategies and Challenges in the States Nathan Bush Vice President of Government Relations.
Concurrent Tobacco Use: A Study of Socio-demographic Correlates Nasir Mushtaq, MPH Laura A Beebe, PhD University of Oklahoma Health Sciences Center.
THE IMPORTANCE OF POINT OF SALE Counter Tobacco Allison E. Myers, MPH Kurt M. Ribisl, PhD Adapted from a presentation given January 16, 2013 Office of.
Smokeless Tobacco: The Next Generation Niki Sue Mueller
Consumer Demand Roundtable Session Two February 1-2, 2006 Academy for Educational Development Washington DC Consumer Demand Roundtable Session Two February.
G. P. Richardson AAHB, March Rockefeller College of Public Affairs and Policy University at Albany System Dynamics Mapping and Modeling for Tobacco.
Tobacco Tax/Price Policies and Smoking Behavior Andrew Hyland, PhD Roswell Park Cancer Institute February 2, 2011
Taking a Public Health Approach to Tobacco Control
The Demand for and Supply of Cessation Products & Services Frank J. Chaloupka University of Illinois at Chicago.
The Use of Commercial Tobacco Among Minority Populations Centers for Disease Control and Prevention Office on Smoking and Health Sydney Lee.
Global Tobacco Surveillance System Accomplishments and Opportunities Samira Asma Associate Director Global Tobacco Control Office on Smoking and Health.
Spit: Tobacco’s Deadliest Little Secret Niki Sue Mueller Program Director Wyoming Through With Chew
Kenneth E. Warner University of Michigan University of Iowa November 15, 2002 Technology, Policy, and the Future of Nicotine Addiction.
Current challenges in tobacco prevention – do new products pose threats or opportunities? Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden.
Taxation and New Products Gregory N Connolly DMD, MPH National Smokeless and Spit Tobacco Summit September 22,2009.
Evidence-based/Best Practices Tobacco Control Hadii Mamudu, PhD, MPA COPH-China Institute November 17, 2011.
METHODS Setting Kansas Study population Kansas Physician Assistants Study design Cross-sectional Measurements / Data points collected A survey consisting.
Smoking Cessation in the Military: Challenges, Solutions, And Issues for Women Smokers Robert C. Klesges, Ph.D. Professor, Department of Preventive Medicine,
Current Trends in Smokeless Tobacco Use Among Wisconsin Adults Daphne Kuo, Karen Palmersheim, Mark Wegner, and Patrick Remington UW Carbone Cancer Center.
Ryan Liptak, Ryan Merk, Mary Frances Meier Microeconomics.
Snus as a Substitution for Smoking: The Swedish Experience Lars M. Ramström Institute for tobacco studies Stockholm, Sweden.
Economics of Tobacco Use and Help-Seeking Behavior Bishwa Adhikari, Ph.D., Economist Office on Smoking and Health Centers for Disease Control and Prevention.
Quitting Cigarettes Completely or Switching to Smokeless Tobacco: Do U.S. Data Replicate the Swedish Results? Shu-Hong Zhu University of California, San.
Is use of illicit tobacco associated with reduced motivation to stop smoking and making a quit attempt? Belinda Iringe-Koko, Ann McNeill, Robert West and.
Le rôle de la réduction de dommages dans la lutte antitabac The role of harm reduction in tobacco control Lars M. Ramström Institute for Tobacco Studies.
PATHFINDER CASE STUDY TOBACCO CONTROL. Points to ponder This is a model, not a definitive analysis Does this model reflect the way outcome is attributed.
Regulatory Science to Policy: Update on e-cigarettes. David B
The impact of the EU accession on Croatia Public health policies on tobacco Marta Čivljak, MD, PHD Research Fellow Department of Medical Sociology and.
Characteristics of new tobacco products emerging on the tobacco market: implications for tobacco control policies Lars M. Ramström Institute for Tobacco.
Global Adult Tobacco Survey (GATS) Funded by Bloomberg Philanthropies.
Smoking cessation aided by low-toxicity smokeless tobacco can save many lives Lars M. Ramström Institute for Tobacco Studies Täby, Sweden UKNSCC 2014 Thursday.
Giving a way free stuff to motivate smokers to call a Quitline North American Quitline Consortium Meeting May 2, 2005.
The Tobacco Tax A WIN, WIN, WIN for KENTUCKY Political Win Fiscal Win Health Win.
On the Road to a Tobacco-Free Ghana Edith Koryo Wellington Senior Research Officer Ghana Health Service.
The Importance of Research in Tobacco Control Jeffrey Koplan, MD, MPH Emory Global Health Institute- China Tobacco Control Partnership.
Cutting tobacco’s death toll − an overview of different options Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden 5th Annual Conference.
Lars M. Ramström PhD Director, Institute for Tobacco Studies Stockholm, Sweden The Swedish experience the role.
The Role of Harm Reduction in Tobacco control – An Update of Pros and Cons Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden 53rd International.
Mary Hrywna, MPH Cristine D. Delnevo, PhD, MPH Dorota Staniewska, MS University of Medicine & Dentistry of New Jersey (UMDNJ) School of Public Health (SPH)
Harvesting Global Learning on Electronic Nicotine Delivery Systems to Inform U.S. Research, Surveillance and Policy JUNE 6-7, 2015 New Zealand A/Professor.
The e-cigarette: opportunity or threat? SSA Annual Symposium 2015 Deborah Arnott Chief Executive Action on Smoking and Health.
Campus Tobacco Use & Prevalence Team Tobacco. Why this study? We wanted to asses the prevalence and perception of tobacco use among Rowan students.
Policies for helping smokers who cannot quit: a prerequisite for maximum prevention of tobacco induced diseases Lars M. Ramström Institute for Tobacco.
Cigarette Companies Going Smokeless – What’s the Legal Response? Micah Berman, JD Executive Director Tobacco Public Policy Center.
By Deepak K Mishra Executive Director Socio Economic and Educational Development Society (SEEDS) Need of Tobacco Control.
National Conference on Tobacco or Health December 2003 Flowers in the Ashcans The Struggle Towards Smoke-Free Hospital Property Christina Krause, MSc,
The Story Behind the Data The Current Scene of Chewing Tobacco, Snuff, or Snus Among Wisconsin Adults Randall Glysch & Kyle Pfister Wisconsin Tobacco Prevention.
5/18/09 TMAAAPHP Tobacco Control Task ForceSlide 1 Tobacco Harm Reduction  Buyer/Hagan/Burr v. Kennedy/Waxman  A Public Health Perspective  Live Video.
Trends in electronic cigarette use in England Robert West Emma Beard Jamie Brown University College London
Electronic Cigarettes Geri Guardino, MPA Policy Analyst, Tobacco Control Program RI Department of Health Tobacco Free Rhode Island Annual Meeting - October.
1 Maintaining downward pressure on smoking prevalence Robert West University College London All Party Parliamentary Group on Smoking September 2015.
Benefits of Increasing Tobacco Taxes By: Tae Kim.
Consumer Research Proposal Exotic Smokes Cigarette Company Tara Appling-Crisp MKT/554 July 18, 2011.
SCoR (Philip Morris) SCoR stands for “Smoke Constituent Reduction” Anticipate broader range of toxin reductions than Omni or Advance Various focus groups.
The Role of Epidemiological Surveillance in Tobacco Control Yang Gonghuan China CDC/PUMC.
Danielle Carroll Tameka Bazile
INFLUENCE OF TOBACCO AND PHARMACEUTICAL INDUSTRIES ON TOBACCO CONTROL PROGRAMS John P. Pierce, Wael Al-Delaimy Karen Messer, Dennis Trinidad & UCSD Tobacco.
Trends in electronic cigarette use in England
Purposes of a Tobacco-Related Surveillance System
Trends in electronic cigarette use in England
a specific MRTP ─ Snus ─ a low-toxicity oral tobacco product.
List 5 reasons why you think
Trends in electronic cigarette use in England
Ministry of Health of the Republic of Uzbekistan
Presentation transcript:

Department of Medicine

The Harm Reduction Debate Current context of the debate - Snus enthusiasts vs. pessimists Switching from cigarettes to snus alone will reduce individual risk But: What will happen on a population basis?

Department of Medicine Current Smokeless Advertising Cigarette-branded smokeless tobacco products Appear to promote dual use Free with purchase of cigarette pack Marketing messages – Convenient, discreet, for smokefree places – New demographic groups?

UST Conference for Investors December 19, 2007

Department of Medicine Data used in Modeling CDC MMWR reports National Health Interview Survey data U.S.T. marketing documents and shareholder presentations Phillip Morris documents IARC Monographs Peer Reviewed Literature Tobacco trade journals

Department of Medicine Modeling Assumptions Four mutually exclusive groups of smokers –Stable –Health concerned –Smoke-free environment –Price sensitive Non-users do not initiate tobacco use as dual users Snus use is not widely prevalent in the U.S. population Changes arise from the current pattern of use Smokeless not used as a cessation aid

Stable

Department of Medicine Health Effect: Base Case ConditionPrevalence Never User56% Quit19.8% Cigarettes21.6% Smokeless1% Dual1.6% Total

Department of Medicine Health Effect: Base Case ConditionPrevalenceRisk Never User56%0 Quit19.8%5 Cigarettes21.6%100 Smokeless1%10 Dual1.6%90 Total

Department of Medicine Health Effect: Base Case ConditionPrevalenceRiskEffect Never User56%00 Quit19.8%50.99 Cigarettes21.6% Smokeless1%100.1 Dual1.6% Total24.1

Department of Medicine Results Health Effect: 24.2 (21.5, 27.2)

ScenarioTransition Probabilities Aggressive smokeless promotion Increase smokeless initiation x10 Health concerned: Increase smokeless use x 10 (half from cigarettes, half from quitters) Dual use among new users.25 Smoke-free environments: Quitting cut in half Cigarette users to smokeless.50 Dual use among new users.75 Price sensitive: Quitting cut in half Cigarette users to smokeless.50 Dual use among new users.25 USTIncrease smokeless initiation by 3.7 Aggressive promotion with most new users from smokers Increase smokeless initiation x 10 75% from smokers; 25% from never users No effect on initiationNo change in initiation patterns

Department of Medicine ScenarioTobacco-related health effect (95% CI) Base Case24.1 ( ) Aggressive smokeless promotion 30.5 ( ) UST24.8 ( ) Aggressive promotion with most new users from smokers 25.9 ( ) No effect on initiation22.3 ( )

Department of Medicine Conclusions Promotion of smokeless as a safer alternative to cigarettes unlikely to provide population health benefits Promotion of smokeless may actually lead to an increase in harm at the population level

Department of Medicine Public Health Implications Other risks of promotion of smokeless as less harmful than cigarettes include: –Undermining effective policies –Confusing public messages –Legitimizing tobacco companies Focus on proven harm reduction strategies that rapidly reduce tobacco use and disease Taxes, regulation, litigation

Department of Medicine

What would have to happen to cut health effects in half? Increase smokeless initiation by 5x, all from cigarettes Cut dual use in smokeless initiators from.40 to.15 Cut smokeless to cigarettes from.17 to.03 All smokers health concerned –Increase smokeless 15x –75% from cigarettes, rest from quitters –25% become dual users Reasonable assumptions?